B. Vidarsson

发表

Recombinant factor VIIa as last‐resort treatment of desperate haemorrhage

P. T. Onundarson, G. Sigurdsson, R. Pálmason, 2012, Acta anaesthesiologica Scandinavica.

Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia

P. T. Onundarson, B. Vidarsson, P. Önundarson, 2000, Thrombosis and Haemostasis.

Genetic architecture of band neutrophil fraction in Iceland

D. Gudbjartsson, A. Jonasdottir, Á. Jónasdóttir, 2022, Communications Biology.

Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.

P. T. Onundarson, J. Morrissey, R. Danielsen, 1998, Scandinavian cardiovascular journal : SCJ.

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome.

P. T. Onundarson, Á. Geirsson, B. Vidarsson, 1995, The American journal of medicine.

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2022, Blood Cancer Journal.

Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries

P. T. Onundarson, J. Ingerslev, B. Sørensen, 2014, Platelets.

Clinical phenotype in heterozygote and biallelic Bernard‐Soulier syndrome—A case control study

P. T. Onundarson, M. K. Magnússon, J. Ingerslev, 2015, American journal of hematology.

A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

William J. Astle, Hannes P. Eggertsson, J. Danesh, 2021, Communications Biology.

Genetic variants associated with platelet count are predictive of human disease and physiological markers

D. Gudbjartsson, U. Thorsteinsdóttir, K. Stefánsson, 2021, Communications Biology.

The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms

A Sigurdsson, G Masson, D. Gudbjartsson, 2014, Leukemia.

A comparison of platelet quality between platelets from healthy donors and hereditary hemochromatosis donors over seven‐day storage

P. T. Onundarson, O. Sigurjonsson, B. Vidarsson, 2020, Transfusion.

Transient effusive‐constrictive pericarditis due to chemotherapy

J. H. Stein, B. Vidarsson, Deane Mosher, 1999, Clinical cardiology.

Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.

P. T. Onundarson, D. Arnar, C. Francis, 2015, The Lancet. Haematology.

Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood Cancer Journal.

Prevalence of MGUS Is High in the Istopmm Study but the Prevalence of IgA MGUS Does Not Increase with Age in the Way Other Immunoglobulin Subtypes Do

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2022, Blood.

Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Estimating Selection Bias in Previous Monoclonal Gammopathy of Undetermined Significance Research - the Importance of Screening: Results from the Population-Based Screening Study Iceland Screens, Treats or Prevents Multiple Myeloma (iStopMM)

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Bernard-Soulier in Iceland. Bleeding Symptoms and Platelet Parameters in Patients, Carriers and Controls.

P. T. Onundarson, M. K. Magnússon, B. Gudmundsdottir, 2006 .

Progressive multifocal leukoencephalopathy after fludarabine therapy for low‐grade lymphoproliferative disease

P. T. Onundarson, M. Salamat, H. Isaksson, 2002, American journal of hematology.

Fludarabine and Cytarabine as a Sequential Infusion Regimen for Treatment of Adults with Recurrent, Refractory or Poor Prognosis Acute Leukemia

D. Mosher, R. Abonour, E. Williams, 2001, Leukemia & lymphoma.

Red blood cell utilization and transfusion triggers in patients diagnosed with chronic lymphocytic leukaemia in Iceland 2003–2016

H. H. Thorvaldsson, B. Vidarsson, A. Halldorsdottir, 2019, Vox sanguinis.

Epidemiology of hairy cell leukemia in Iceland.

G. Eyjolfsson, P. T. Onundarson, B. Agnarsson, 2002, The hematology journal : the official journal of the European Haematology Association.

Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial

P. T. Onundarson, D. Arnar, C. Francis, 2017, Journal of Thrombosis and Thrombolysis.

Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

A ‘pilot’ study on air‐travel and venous thromboembolism

P. T. Onundarson, T. Love, V. Rafnsson, 2009, British journal of haematology.

Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study

I. Olafsson, B. Agnarsson, T. Aspelund, 2022, Blood.

Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

D. Gudbjartsson, T. Thorgeirsson, U. Thorsteinsdóttir, 2023, Nature Genetics.

Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance

P. T. Onundarson, B. Agnarsson, T. Aspelund, 2024, Annals of Internal Medicine.